https://radiologykey.com/essential-equipment-puncture-needles/

In the pharmaceutical industry and research and development field, the puncture needle technology has evolved from a simple sample collection tool to a key supporting technology throughout the entire process of drug discovery, development, and production. Its precise micro-operation capability, controllable penetration depth, and compatibility with automated systems make it an indispensable part of modern drug research and development, especially playing a unique role in high-throughput screening, formulation research, and quality control.

During the drug discovery stage, microneedle technology accelerates the screening and validation of candidate compounds. Traditional drug screening usually uses 96-well plates or 384-well plates, but microneedle arrays can reduce the experimental scale to 1536 or even 3456 wells, reducing reagent consumption to micro-level and significantly increasing the screening throughput. By precisely distributing nanoliter-level compound solutions through microneedles, researchers can simultaneously test thousands of compounds for their activity against specific targets, accelerating lead compound discovery. In cell-level screening, microneedles can precisely puncture the cell membrane, introducing DNA, RNAi, or CRISPR components into specific cell compartments, enabling efficient genetic manipulation, evaluating gene functions, or verifying drug targets.

The puncture needle technology is particularly crucial in the development of pharmaceutical preparations, especially in the development of transdermal drug delivery systems. Transdermal preparations need to overcome the skin barrier, and traditional penetration enhancers have limited effects and may cause irritation. Through micro-needle arrays, researchers can systematically study the effects of different needle lengths, densities, shapes, and materials on drug penetration, and optimize the formulation parameters. In in vitro skin penetration studies, micro-needle-treated skin is combined with Franz diffusion chambers to accurately determine drug permeation kinetics and predict in vivo behavior. The research on formulations that can dissolve micro-needles involves the selection of biodegradable materials (such as hyaluronic acid, gelatin, poly(lactic acid), etc.), optimization of drug encapsulation processes, and control of release kinetics, which are all challenges that traditional pharmaceutics have not addressed.

In the era of biologics, the development of large molecule drugs poses new requirements for delivery technologies. Monoclonal antibodies, vaccines, gene therapy vectors, etc. are usually unable to penetrate biological barriers. Traditional injection methods have problems such as poor patient compliance and the need for professional operation. Micro-needle technology provides non-invasive or minimally invasive delivery solutions for these biological agents. During the research and development process, scientists need to evaluate the impact of different micro-needle designs on the stability of biological macromolecules, and optimize the formulation to maintain the natural conformation and biological activity of proteins. In accelerated stability studies, micro-needle arrays can quickly assess the shelf life of the formulation under different temperatures and humidity conditions, significantly shortening the development time.

In the pharmaceutical production process, the puncture needle technology also plays a crucial role in quality control. In online process analysis technology (PAT), micro probes can monitor key parameters such as pH, dissolved oxygen, and metabolite concentration in the reactor in real time without affecting the reaction process or introducing contamination risks. In the aseptic filling stage, the micro-needle sampling system can extract samples for aseptic inspection without damaging the product's sealing, which is more economical and efficient than traditional destructive sampling. In the automatic visual inspection system, micro-needles can precisely remove tiny foreign objects from the pharmaceutical packaging, improving product cleanliness.

In recent years, the trends of continuous pharmaceutical production and personalized drug preparation have further enhanced the value of puncture needle technology. On continuous production lines, the micro-needle system can achieve precise addition and online mixing of trace components, ensuring uniformity. For dose adjustments for special groups such as children and those with impaired liver and kidney function, micro-needle patches can easily achieve individualized dosing, which is difficult to achieve with traditional tablets. The combination of 3D printing and micro-needle technology can even immediately prepare personalized transdermal preparations according to prescriptions, marking a shift in the pharmaceutical model from "batch production" to "on-demand production."

In the future, with the advancement of Pharmaceutical 4.0 and intelligent manufacturing, the puncture needle technology will become more integrated and automated. The robot-controlled micro-needle system can conduct round-the-clock drug screening; the artificial intelligence algorithm can predict the performance of the formulation based on the micro-needle penetration data; and the blockchain technology can trace the entire process of micro-needle preparations from research and development to production, ensuring the integrity of data and product consistency. These innovations will jointly drive the pharmaceutical industry towards a more efficient, more flexible, and more personalized direction.